BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 27
• 28
• 29
• 30

• Deals

  Osiris Therapeutics, Inc. and NuVasive, Inc. Enter into Definitive Agreement for Osteocel(R) for Up to $85 Million in Upfront and Milestone Payments

  May 8, 2008

   · 

  7 min read
• Policy

  FDA Grants Priority Review of Talecris Biotherapeutics’s Gamunex(R) as a Treatment for Neurological Disorder CIDP

  May 8, 2008

   · 

  4 min read
• FDA

  S.Korea Approves Zeltia Group Cancer Drug Yondelis

  May 8, 2008

   · 

  1 min read
• Drug Development

  BiPar Sciences, Inc. Expands Phase 2 Clinical Trials of BSI-201, a Novel DNA Repair Inhibitor, in Ovarian Cancer

  May 8, 2008

   · 

  2 min read
• FDA

  Osiris Therapeutics, Inc. Receives Approval for Use of Prochymal(TM) Under FDA Expanded Access Treatment Program

  May 8, 2008

   · 

  7 min read
• Business

  James T. Glover Appointed to Board of Directors of Varian, Inc.

  May 8, 2008

   · 

  1 min read
• Drug Development

  BioDelivery Sciences International BEMA(TM) Fentanyl Phase III Data Demonstrating Efficacy and Tolerability to be Presented at American Pain Society Annual Meeting

  May 8, 2008

   · 

  5 min read
• Policy

  AstraZeneca PLC Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines

  May 8, 2008

   · 

  11 min read
• FDA

  Boston Scientific Corporation Announces FDA Approval of New Family of Advanced Pacemakers

  May 8, 2008

   · 

  4 min read
• FDA

  CorMatrix Announces FDA 510(k) for Novel Biomaterial Implant for Intracardiac Repair

  May 8, 2008

   · 

  5 min read